Meridian Medical wins $129M contract for nerve agent antidote DuoDote

Meridian Medical Technologies, a unit of Kindeva, secured a $129 million contract to supply the U.S. with the nerve agent antidote autoinjector DuoDote. The autoinjectors will be produced in St. Louis.

“This contract underscores the ongoing importance of maintaining readiness against potential threats.”fiercepharma.com

• 1 source
• fiercepharma.comKindeva unit Meridian Medical snares $129M to supply US with nerve agent antidoteJoseph KeenanJan 22, 2025

Summarized from public sources; check the original articles before acting on it.